- Report
- February 2021
- 50 Pages
Global
From €2896EUR$3,250USD£2,512GBP
- Report
- April 2020
- 80 Pages
Global
From €3520EUR$3,950USD£3,054GBP
- Report
- July 2024
- 120 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- February 2024
- 115 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- February 2024
- 113 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- April 2023
- 115 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- August 2022
- 115 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- August 2022
- 104 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- August 2022
- 120 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- July 2024
- 150 Pages
Global
From €3342EUR$3,750USD£2,899GBP
- Report
- July 2024
- 150 Pages
Global
From €3342EUR$3,750USD£2,899GBP
- Report
- June 2024
- 200 Pages
Global
From €7084EUR$7,950USD£6,146GBP
- Report
- May 2023
- 450 Pages
Global
From €4456EUR$5,000USD£3,865GBP
- Report
- November 2023
- 209 Pages
Global
From €3965EUR$4,450USD£3,440GBP
- Report
- September 2023
- 138 Pages
Global
From €3965EUR$4,450USD£3,440GBP
- Report
- August 2022
- 120 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- November 2023
- 77 Pages
France
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- July 2024
- 110 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- July 2024
- 120 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- February 2024
- 120 Pages
Global
From €4233EUR$4,750USD£3,672GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more